• Home
    • Concept
  • Program
    • Speakers
  • CardioMedLive
  • Livestream
  • On-demand
  • 2022 Symposia
  • Contacts
    • Data Privacy Policy
    • Legal Notice
  • Location
  • Registration
info@medupdate-europe.eu
Login

Login
Cardio Update Europe 2023Cardio Update Europe 2023
Cardio Update Europe 2023
30 June - 1 July - Vienna & Virtual
  • Home
    • Concept
  • Program
    • Speakers
  • CardioMedLive
  • Livestream
  • On-demand
  • 2022 Symposia
  • Contacts
    • Data Privacy Policy
    • Legal Notice
  • Location
  • Registration

Scientific Board

boehm

Michael Böhm

Institution:
University Saarland, Homburg/Saar, Germany

Read More
Training:
1977 – 1984 Medical School; Medical School of Hannover
1984 – 1986 Pharmacology; University of Hamburg
1986 – 1993 Internal Medicine and Cardiology; University of Munich
1993 – 2000 Professor of Cardiology; University of Cologne
2000 Professor of Internal Medicine and Cardiology; University of the Saarland, Homburg/Saar

Scientific Career
1980 – 1983 Head of Department of Internal Medicine, Pulmonology and Critical Care Medicine Thoraxklinik Heidelberg

Speciality certification:
1980 – 1983 Training in pharmacology in the Division of Biochemical Pharmacology at the Medical University of Hannover
1984 Doctoral thesis in the Medical Faculty at the Medical University of Hannover (Dept. Biochemical Pharmacol)
1984 – 1986 Resident of the Division of General Pharmacology at the University Hospital of Eppendorf of the University of Hamburg
1986 – 1993 Resident at the Medizinische Klinik I, Klinikum Großhadern, Department of Internal Medicine and Cardiology, Ludwig-Maximilians-Universität München
1992 Certification of Internal Medicine
1993 Assistant Professor of Cardiology at the Klinik III für Innere Medizin, University of Cologne
1993 Certification of Cardiology
1994 Heisenberg-Programm of the Deutsche Forschungsgemeinschaft (DFG)
1995 – 2000 C3-Professorship for Internal Medicine and Cardiology, Innere Medizin III, University of the Cologne
2000 C4-Professorship and Director for Internal Medicine, Cardiology, Angiology and Intensiv Care Medicine, University of the Saarland, Homburg/Saar
2007 President Elect of the German Cardiac Society
2009 President of the German Cardiac Society
2010 Board member and Chairman of the Scientific Program Committee of the European Society of Cardiology (ESC)
2012 Honorary member and medal of merit of the Hungaria Society of Cardiology
2012 Order and Cross of Merit of the Federal Republic of Germany

Scientific Journals
Chief Editor: Clinical Research in Cardiology
Consulting Editor: Basic Research in Cardiology
Editorial Board: Cardiovascular Research, Cardiovascular Drugs and Therapy, European Heart Journal
Reviewer: Circulation, Circulation Research, Hypertension, Lancet, European Journal of Heart Failure, European Heart Journal and others

Trial Experience
National Coordinator: COMET, CORONA, ONTARGET, TRANSCEND, SENIORS, ESSENTIAL
Executive Board: SHIFTDSMBRECORD
Steering Committee: CORONA, ONTARGET, TRANSCEND, SENIORS, ESSENTIAL, ASTRONAUT
Principal Investigator: OPTILINK, EDIfY

Topic

Heart Failure
huber

Kurt Huber

Institution:
Clinic Ottakring, 3rd Medical Department, Cardiology & Intensive Care Medicine, Vienna, Austria

Read More
Kurt Huber is Director of the 3rd Medical Department, Cardiology and Intensive Care Medicine, at the Clinic Ottakring, Montleartstrasse 37, in A-1160 Vienna, Austria since 2002. This is a tertiary cardiology department with all interventional (coronaries, non-coronaries, rhythmology, TAVI) facilities, 81 beds, including 9 CCU/ICU beds. The department is part of the VIENNA STEMI network, which has been organized by Prof. Huber since 2003.

Training
Prof. Huber received his medical degree in 1979 from the University of Vienna Medical School, and completed his postdoctoral training at the Universities of Vienna and Innsbruck, Austria. Qualified as a specialist in internal medicine (1986), cardiology (1988), and internal intensive care (2002), he served as Associate Professor of Internal Medicine, and was Director of the outpatient ward of the Department of Cardiology at the University of Vienna (1986-1994). In 1995, he became Professor of Internal Medicine and Cardiology at the University of Medicine in Vienna, served as Director of a patient ward and the scientific laboratory of the department (1995-2002).

Position in ESC and Professional Organizations
Prof. Huber is permanently engaged since many years in activities of the European Society of Cardiology (ESC): he served as member for the EU Relation Committee (2002-2004), is part of the Editor’s Club as responsible editor of the Austrian Journal of Cardiology and he is member of the ESC Press Committee since 2005 and chair of the committee since 2010. He was engaged in the WG on Thrombosis as nucleus member, treasurer, vice chair, chair, past chair and ex officio member within the past 10 years and is at present nucleus member and web/press coordinator of the Association of Acute Cardiovascular Care of the ESC. Prof. Huber has been secretary general of the Austrian Society of Cardiology from 1999-2007, took over the position of president between 2007 and 2009 and past president from 2009-2011.

Editorial Boards
Prof. Huber is on the editorial boards of numerous medical journals including the European Heart Journal, Thrombosis and Haemostasis, The European Heart Journal on Acute Cardiovascular Care (EHJ-ACC) and the Journal of Thrombosis and Thrombolysis, and serves as the main editor of the Austrian Journal of Cardiology.

Fellowships
Prof. Huber is fellow of the European Society of Cardiology (FESC since 1993), of the American College of Cardiology (FACC since 1993), and of the American Heart Association (FAHA since 1998), respectively.

Major Publications
As author or co-author Prof. Huber has gathered to date more than 500 peer-reviewed publications, including his active co-authorship in ESC guidelines on ST-Elevation MI (2008, 2012), myocardial revascularization (2010), non-ST-elevation acute coronary syndrome (2011), and non-cardiac surgery (2014).

Major research interest
Prof. Huber’s major research interest are the pathophysiology, diagnosis, and treatment of ACS (UA, NSTEMI, STEMI); mechanisms of restenosis and stent thrombosis; the plasmin activation system in disease; reperfusion strategies in STEMI, STEMI networks; anticoagulation and antiplatelet therapy in cardiovascular diseases; the role of platelet function testing; statins; diabetes in heart; and SNPs research (for CYP 450 isoenzymes), respectively

Topic

Acute & Chronic Coronary Syndroms – interventional and conservative treatments
Keren_2019

Andre Keren

Institution:
Heart Failure and Heart Muscle Disease Center, Hadassah University Hospital, Jerusalem, Israel

Read More
Andre Keren is the Director of the Heart Failure and Heart Muscle Disease Center, Hadassah University Hospital in Jerusalem.

Andre Keren is Professor Emeritus of Medicine (Cardiology) at Hadassah-Hebrew University School of Medicine Professional Activities

1982-1984 Post Doctoral Fellow, Cardiology Division, Department of Medicine, Stanford University Hospital, Stanford, California, USA.
1993-1994 Visiting Associate Professor, Department of Medicine, Division of Cardiology, Stanford University Hospital, Stanford, California, USA. 1997-2001 Chairman of the Working Group on Myocardial and Pericardial Diseases of the Israeli Society of Cardiology
1999 – 2006 Director, Department of Cardiology, Bikur Cholim Hospital, Jerusalem, affiliated with the Hebrew University – Hadassah Medical School, Jerusalem, Israel
1999-2006 Chairman of the Jerusalem Heart Chapter of the Israel Heart Society
2001- 2004 Chairman of the National Board of Examinations in Cardiology 2006 Visiting Professor, University College of London Hospitals, London, United Kingdom
2006 – 2008 Member of the Task Force of the European Society of Cardiologyfor Guidelines of “Diagnosis and Treatment of Acute and Chronic Heart Failure 2008”.
2006- 2008 Chairman of the Working Group of Myocardial and Pericardial Diseases, of the European Society of Cardiology
2006 – 2015 Director, Heart Failure and Heart Muscle Disease Center, Hadassah-Hebrew University Hospital, Jerusalem, Israel
2014- Coordinator of National Society Meetings in the Congress Program Committee of the European Society of Cardiology
2013- Member, National Committee of Medical Accreditation of the Health Ministry 2013 – Official representative of the Israel Heart Society in the Israeli Ministry of Health Committee for revision of the regulations of athletes’ screening
2015 – Member of the National Cardiology Advisory Board of the Ministry of Health 2015- Senior Cardiologist, Hadassah-Hebrew University Hospital, Dept of Cardiology
2015 – Director of Heart Failure Services, Clalit HMO, Jerusalem District
2015 – Director of Heart Institute, Assuta Hashalom Tel Aviv, Assuta Hospitals

Fellowships: Fellow of the European Society of Cardiology, American College of Cardiology, American Heart Association Council on Cardiovascular Sciences, Israel Heart Society, International Society of Cardiovascular Ultrasound, Honorary Member of the Romanian Society of Cardiology

Publications Over 170 published papers in peer-reviewed journals

Topic

Cardiomyopathy/Myocarditis

In cooperation with

Accreditation

The Cardio Update Europe 2023 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 10 European CME credits (ECMEC®s).

Accreditation – EFPIA & Ethical Medtech

The Cardio Update Europe 2023 has been assessed COMPLIANT by The European Federation of Pharmaceutical Industries and Associations (EFPIA) and the MedTech Europe Code of Ethical Business Practice.

Follow us

Newsletter Subscription

Click here to receive news about your interest area. Unsubscribe at any time.

ethical medtech

www.ethicalmedtech.eu

© 2023

  • Home
  • Legal Notice
  • Data Privacy Policy
  • Contacts
  • Cookie policy (EU)
Manage Cookie Consent
We use cookies to optimize our website and our service. Please choose, which kind of cookies you'd like to accept.
Functional cookies Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}